Tarsus Pharmaceuticals, Inc. (TARS)

Typically moves ±5.09% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-11-06 APPROXIMATE

Since Mar 31, 2021, Tarsus Pharmaceuticals, Inc. (TARS) has reported earnings 23 times. On average the shares move ±5.09% post-earnings, with a positive reaction 65.2% of the time. Its largest post-earnings gain was +15.15% (Aug 06, 2025) and its largest decline was -9.33% (Feb 25, 2025). The next earnings report is predicted for 2026-11-06 (approximate).

Earnings reactions

How TARS moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±5.09%

Positive %

65.2%

Negative %

34.8%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 06, 2026	☀ PRE	+6.87%	open_in_new
May 06, 2026	☽ POST	-1.46%	open_in_new
Feb 23, 2026	☽ POST	+7.79%	open_in_new
Nov 04, 2025	☽ POST	-4.62%	open_in_new
Aug 06, 2025	☽ POST	+15.15%	open_in_new
May 01, 2025	☽ POST	-5.84%	open_in_new
Feb 25, 2025	☀ PRE	-9.33%	open_in_new
Nov 13, 2024	☽ POST	+0.31%	open_in_new
Aug 08, 2024	☽ POST	+13.72%	open_in_new
May 08, 2024	☽ POST	-8.86%	open_in_new
Feb 27, 2024	☽ POST	-3.44%	open_in_new
Nov 09, 2023	☽ POST	+12.2%	open_in_new
Aug 10, 2023	☽ POST	-1.12%	open_in_new
May 09, 2023	☽ POST	+3.79%	open_in_new
Mar 13, 2023	☽ POST	+0.85%	open_in_new
Nov 09, 2022	☽ POST	+1.41%	open_in_new
Aug 11, 2022	☽ POST	+6.81%	open_in_new
May 10, 2022	☽ POST	-3.68%	open_in_new
Mar 14, 2022	☽ POST	+1.03%	open_in_new
Nov 09, 2021	☽ POST	+1.89%	open_in_new
Aug 05, 2021	☽ POST	+0.08%	open_in_new
May 11, 2021	☽ POST	+4.66%	open_in_new
Mar 31, 2021	☽ POST	+2.17%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±5.09%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 30 →

Funds holding

$882663952

Total value held

Buying

23 added · 7 reduced

Blackrock, Inc.

$242705264 +8.54%

Janus Henderson Group Plc

$157222823 NEW BUY

Morgan Stanley

$114996594 -6.03%

Bank Of America Corp /De/

$75098874 -0.10%

State Street Corp

$67531536 +9.68%

SEC Filing Types

description SCHEDULE 13G/A

12 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
144	20260904	open_in_new SEC.gov
144	20260904	open_in_new SEC.gov
144	20260904	open_in_new SEC.gov
144	20260904	open_in_new SEC.gov
4	20260903	open_in_new SEC.gov
4	20260903	open_in_new SEC.gov
144	20260902	open_in_new SEC.gov
144	20260902	open_in_new SEC.gov
144	20260902	open_in_new SEC.gov
144	20260902	open_in_new SEC.gov

Frequently asked about TARS earnings

When does Tarsus Pharmaceuticals, Inc. report earnings next? expand_more

Tarsus Pharmaceuticals, Inc. (TARS)'s next earnings date is approximate for 2026-11-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does TARS stock move after earnings? expand_more

Over 23 reports, TARS has moved an average of ±5.09% the session after earnings, closing higher 65.2% of the time.

What was TARS's biggest post-earnings move? expand_more

TARS's largest post-earnings gain on record was +15.15% on Aug 06, 2025, and its largest decline was -9.33% on Feb 25, 2025.

Where can I find Tarsus Pharmaceuticals, Inc.'s SEC filings? expand_more

All of Tarsus Pharmaceuticals, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.